最終更新日：2022/12/24
The European Commission cleared the biogeneric version of the drug known as epoetin alfa, Novartis, based in Basel, Switzerland, said yesterday.
編集履歴（0）
The European Commission cleared the biogeneric version of the drug known as epoetin alfa, Novartis, based in Basel, Switzerland, said yesterday.
DiQt（ディクト）
無料
★★★★★★★★★★
